Clinical Trial Update: Effects of Empagliflozin on Endogenous Glucose Production in End Stage Renal Disease(ESRD). [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of empagliflozin on endogenous glucose production in patients with end stage renal disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: University of Pisa | Conditions: End Stage Renal Disease | Phase 2 | Status: COMPLETED